Improved albendazole dissolution rate in pluronic 188 solid dispersions

AAPS PharmSciTech

Volumn 11, Issue 4, 2010, Pages 1518-1525

  Castro, Silvina G ^a   Bruni, Sergio Sanchez ^b   Lanusse, Carlos E ^b   Allemandi, Daniel A ^a   Palma, Santiago D ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b Facultad de Ciencias Veterinarias   (Argentina)

Author keywords

albendazole; dissolution rate; poloxamer; solid dispersions; surfactant

Indexed keywords

ALBENDAZOLE; POLOXAMER; POLYMER;

AQUEOUS SOLUTION; ARTICLE; DRUG FORMULATION; DRUG SOLUBILITY; FOURIER TRANSFORM MASS SPECTROMETRY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STEADY STATE; X RAY DIFFRACTION;

ALBENDAZOLE; ANTHELMINTICS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HARDNESS TESTS; POLOXAMER; POLYETHYLENE GLYCOLS; POVIDONE; SOLUBILITY;

EID: 78651470722     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9517-6     Document Type: Article

References (43)

1. C Leuner J Dressman 2000 Improving drug solubility for oral delivery using solid dispersions Eur J Pharm Biopharm 50 1 47 60 1:CAS:528: DC%2BD3cXjslyju7c%3D 10.1016/S0939-6411(00)00076-X 10840192 (Pubitemid 30326688)
2. GL Amidon H Lennernnas VP Shah JR Crison 1995 A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug 410 product dissolution and in vivo bioavailability Pharm Res 12 413 420 1:CAS:528:DyaK2MXksVGqur8%3D 10.1023/A:1016212804288 7617530
3. E Georgarakis MP Sigalas K Avgoustakis D Bikiaris E Karava 2007 Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions Eur J Pharm Biopharm 66 334 347 10.1016/j.ejpb.2006.11.020 17267194 (Pubitemid 46778978)
4. K Sekiguchi N Obi 1964 Studies on absorption of eutectic mixture. II. Absorption of fused conglomerates of chloramphenicol and urea in rabbits Chem Pharm Bull 12 134 144 1:CAS:528:DyaF2cXosFGgtA%3D%3D 14126741
5. G Levy 1963 Effect of particle size on dissolution and gastrointestinal absorption rates of pharmaceuticals Am J Pharm Sci Support Public Health 135 78 92 1:CAS:528:DyaF3sXktlCqsbY%3D 13930259
6. JL Kanig 1964 Properties of fused mannitol in compressed tablets J Pharm Sci 53 188 192 1:CAS:528:DyaF2cXmtVWitQ%3D%3D 10.1002/jps.2600530217 14123962
7. S Janssens H de Novoa Armas CJ Roberts G Van den Mooter 2008 Characterization of ternary solid dispersions of Itraconazole in polyethylene glycol 6000/polyvidone-vinylacetate 64 blends Eur J Pharm Biopharm 69 3 1114 1120 1:CAS:528:DC%2BD1cXpt1Gqsbg%3D 10.1016/j.ejpb.2008.02.007 18502629
8. X Wang A Michoel G Van den Mooter 2004 Study of the phase behavior of polyethylene glycol 6000-itraconazole solid dispersions using DSC Int J Pharm 272 1-2 181 187 1:CAS:528:DC%2BD2cXhs1GhsL0%3D 10.1016/j.ijpharm.2003.11.026 15019081 (Pubitemid 38293023)
9. H Konno T Handa DE Alonzo LS Taylor 2008 Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine Eur J Pharm Biopharm 70 2 493 499 1:CAS:528:DC%2BD1cXhtFOmtbnE 10.1016/j.ejpb.2008.05. 023 18577451
10. MT Marín MV Margarit GE Salcedo 2002 Characterization and solubility study of solid dispersions of flunarizine and polyvinylpyrrolidone Farmaco 57 9 723 727 10.1016/S0014-827X(02)01262-4 12385522 (Pubitemid 35287006)
11. T Vasconcelos B Sarmiento P Costa 2007 Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs Drug Discov Today 12 1068 1075 1:CAS:528:DC%2BD2sXhsVSmurnF 10.1016/j.drudis.2007.09.005 18061887 (Pubitemid 350186132)
12. Collett JH, Popli H. Poloxamer. In: Kibbe AH, editor. Handbook of Pharmaceutical Excipients. London; 2000. p. 385-388.
13. H Zhai S Li G Andrews D Jones S Bella G Walker 2009 Nucleation and growth in fluidised hot melt granulation Powder Technol 189 2 230 237 1:CAS:528:DC%2BD1MXhtVCksrk%3D 10.1016/j.powtec.2008.04.021
14. T Vilhelmsen H Eliasen T Schaefer 2005 Effect of a melt agglomeration process on agglomerates containing solid dispersions Int J Pharm 303 1-2 132 142 1:CAS:528:DC%2BD2MXhtVanu7fE 10.1016/j.ijpharm.2005.07.012 16139973 (Pubitemid 41318030)
15. Martindale. The complete drug reference. In: Sweetman CS, editors. Pharmaceutical Press, 33rd edn. London; 2002. p. 30-32.
16. H Wen RRC New PS Craig 1993 Diagnosis and treatment of human hydatidosis Br J Clin Pharm 35 565 574 1:STN:280:DyaK3szhvFylug%3D%3D
17. OH Del-Brutto Sotelo GC Roman 1993 Therapy for neurocysticercosis: a reappraisal Clin Infect Dis 17 730 735
18. P Waller 2003 Global perspectives on nematode parasite control in livestock: the need to adopt alternatives to chemotherapy, with emphasis in biological control Anim Health Res Rev 4 35 43 10.1079/AHRR200350 12885207
19. DG Colley PT LoVerde L Savioli 2001 Infectious disease. Medical helminthology in the 21st century Science 293 5534 1437 1438 1:CAS:528:DC%2BD3MXmsVektLg%3D 10.1126/science.1060733 11520969 (Pubitemid 32801534)
20. L Alvarez L Mottier C Lanusse 2007 Drug transfer into target helmint parasites Trends Parasitol 23 3 97 104 1:CAS:528:DC%2BD2sXit1Grtbo%3D 10.1016/j.pt.2007.01.003 17236810 (Pubitemid 46274501)
21. S Sánchez Bruni D Jones Q McKellar 2006 Pharmacological approaches towards rationalizing the use of endoparasitic drugs in small animals J Vet Pharmacol Ther 29 6 443 457 10.1111/j.1365-2885.2006.00806.x 17083448 (Pubitemid 44684087)
22. E Roberson M Burke 1982 Evaluation of granulated fenbendazole as a treatment of helminth infection in dogs J Am Vet Med Assoc 180 53 55 1:STN:280:DyaL387hvFyjug%3D%3D 7056663
23. D Jacobs 1987 Anthelmintics for dogs and cats Int J Parasitol 17 511 518 1:STN:280:DyaL2s3itFWksQ%3D%3D 10.1016/0020-7519(87)90127-5 3294663 (Pubitemid 17058622)
24. G Edwards A Breckenridge 1988 Clinical pharmacokinetics of anthelmintic drugs Clin Pharm 15 67 93 1:CAS:528:DyaL1cXls1aktr8%3D
25. H Jung L Medina L Garcia I Fuentes MR Esparza 1998 Absorption studies of albendazole and some physicochemical properties of the drug and its metabolite albendazole sulphoxide J Pharm Pharmacol 50 43 48 1:CAS:528:DyaK1cXhtFGitb0%3D 9504433
26. K Daniel-Mwambete S Torrado C Cuesta-Bandera F Ponce-Gordo JJ Torrado 2004 The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs Int J Pharm 272 29 36 1:CAS:528: DC%2BD2cXhs1Giurc%3D 10.1016/j.ijpharm.2003.11.030 15019066 (Pubitemid 38293008)
27. M Vogt K Kunath JB Deessman 2008 Dissolution improvement of four poorly water soluble drugs by cogrinding with commonly used excipients Eur J Pharm Biopharm 68 2 330 337 1:CAS:528:DC%2BD1cXlsF2rsQ%3D%3D 10.1016/j.ejpb.2007.05. 009 17574401
28. S Torrado JJ Torrado R Cardoniga 1996 Preparation, dissolution and characterization of albendazole solid dispersions Int J Pharm 140 247 250 1:CAS:528:DyaK28XlsFWrsrc%3D 10.1016/0378-5173(96)04586-3 (Pubitemid 26292771)
29. B Evrard, et al. 2002 Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-β-cyclodextrin J Control Release 85 1-3 13 45-50
30. F Palomares-Alonso H Jung-Cook J Pérez-Villanueva JC Piliado S Rodríguez-Morales G Palencia-Hernández, et al. 2009 Synthesis and in vitro cysticidal activity of new benzimidazole derivatives Eur J Med Chem 44 4 1794 1800 1:CAS:528:DC%2BD1MXjtVSitL4%3D 10.1016/j.ejmech.2008.05.005 18582991
31. JC Rivera L Yépez-Mulia A Hernández-Campos R Moreno-Esparza R Castillo G Navarrete-Vázquez, et al. 2007 Biopharmaceutic evaluation of novel anthelmintic (1H-benzimidazol-5(6)-yl) carboxamide derivatives Int J Pharm 343 159 165 1:CAS:528:DC%2BD2sXpsl2itbw%3D 10.1016/j.ijpharm.2007.05.013 17624700 (Pubitemid 47334867)
32. PC Schmidt P Rubensdorfer 1994 Evaluation of Ludipress as a 'Multipurpose Excipient' for direct compression. Part I: powder characteristics and tableting properties Drug Dev Ind Pharm 20 18 2899 2925 1:CAS:528:DyaK2cXmtFartro%3D 10.3109/03639049409042687
33. Lantz RJ, Schwartz JB. Mixing. In: Lieberman HA, Lachman L, Schwartz JB, editors. Pharmaceutical dosage form: tablets, vol. 2. New York: Marcel Dekker; 1990.
34. SA Maskarinek J Hannig RC Lee KY Lee 2002 Direct observation of poloxamer 188 insertion into lipid monolayers Biophys J 82 1453 1459 10.1016/S0006- 3495(02)75499-4
35. Y Chen GGZ Zhang J Neilly K Marsh D Mawhinney YD Sanzgiri 2004 Enhancing the bioavailability of ABT-963 using solid dispersion containing pluronic F-68 Int J Pharm 286 69 80 1:CAS:528:DC%2BD2cXovVSksbk%3D 10.1016/j.ijpharm.2004.08. 009 15501003 (Pubitemid 39410474)
36. BK Nanjawade FV Manvi AS Manjappa 2007 In situ-forming hydrogels for sustained ophthalmic drug delivery J Control Release 122 2 119 134 1:CAS:528:DC%2BD2sXhtVSktbjO 10.1016/j.jconrel.2007.07.009 17719120 (Pubitemid 47361409)
37. G Dumortier JL Grossiord F Agnely JC Chaumeil 2006 A review of Poloxamernext term 407 pharmaceutical and pharmacological characteristics Pharm Res 23 12 25 10.1007/s11095-006-9104-4 (Pubitemid 44885361)
38. NA Peppas JJ Sahlin 1989 A simple equation for description of solute release. III. Coupling of diffusion and relaxation Int J Pharm 57 169 172 1:CAS:528:DyaK3cXhtVClu74%3D 10.1016/0378-5173(89)90306-2 (Pubitemid 20011841)
39. PL Ritger NA Peppas 1987 A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices J Control Release 5 37 42 1:CAS:528:DyaL2sXkvVeku7s%3D 10.1016/0168-3659(87)90035-6 (Pubitemid 17106644)
40. HA Andreetta 2003 Fármacos de acción prolongada: mecanismos de liberación. Usos de distintos modelos Lat Am J Pharm 22 4 355 364 1:CAS:528:DC%2BD2cXhtFKrtbo%3D
41. KV Kabanov EV Batrakova VY Alakhov 2002 Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery J Control Release 82 189 212 1:CAS:528:DC%2BD38XlvFOktb4%3D 10.1016/S0168-3659(02)00009-3 12175737 (Pubitemid 34880178)
42. MC Jones JC Leroux 1999 Polymeric micelles-a new generation of colloidal drug carriers Eur J Pharm Biopharm 48 101 111 1:CAS:528:DyaK1MXmtVymurk%3D 10.1016/S0939-6411(99)00039-9 10469928 (Pubitemid 29401986)
43. Wells J. Pharmaceutical preformulation: physical chemical properties of drug substances. In: Aulton ME, editor. Pharmaceutics. The science of dosage form design. London: Churchill-Livington; 2007.